{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:58:26Z","timestamp":1774353506068,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T00:00:00Z","timestamp":1313539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00216-011-5278-7","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T13:14:38Z","timestamp":1313586878000},"page":"1923-1933","source":"Crossref","is-referenced-by-count":31,"title":["Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry"],"prefix":"10.1007","volume":"401","author":[{"given":"Yong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangchae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnie","family":"Gee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"key":"5278_CR1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. New Engl J Med 353:487\u2013497","journal-title":"New Engl J Med"},{"key":"5278_CR2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1524-4733.2003.65269.x","volume":"6","author":"J Cramer","year":"2003","unstructured":"Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J (2003) Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 6:566\u2013573","journal-title":"Value Health"},{"key":"5278_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0895-4356(97)00041-3","volume":"50","author":"J Ickovics","year":"1997","unstructured":"Ickovics J, Meisler AW (1997) Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiology 50:385\u2013391","journal-title":"J Clin Epidemiology"},{"key":"5278_CR4","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.276.24.1955","volume":"276","author":"GF Vanhove","year":"1996","unstructured":"Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF (1996) Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 276:1955\u20131956","journal-title":"JAMA"},{"key":"5278_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 133:21\u201330","journal-title":"Ann Intern Med"},{"key":"5278_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/374569a0","volume":"374","author":"JH Condra","year":"1995","unstructured":"Condra JH, Schleif WA, Blahy OM, Gabryelski LJ, Graham DJ, Quintero JC, Rhodes A, Robbins HL, Roth E, Shivaprakash M, Titus D, Yang T, Tepplert H, Squires KE, Deutsch PJ, Emini EA (1995) In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374:569\u2013571","journal-title":"Nature"},{"key":"5278_CR7","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pmed.0020016","volume":"2","author":"JA Salomon","year":"2005","unstructured":"Salomon JA, Hogan DR, Stover J, Stanecki KA, Walker N, Ghys PD, Schwartl\u00e4nder B (2005) Integrating HIV prevention and treatment: from slogans to impact. PLoS Med 2:e16","journal-title":"PLoS Med."},{"key":"5278_CR8","first-page":"96","volume":"40","author":"J Castilla","year":"2005","unstructured":"Castilla J, Del Romero J, Hernando V, Marincovich B, Garc\u00eda S, Rodr\u00edguez C (2005) Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J AIDS 40:96\u2013101","journal-title":"J AIDS"},{"key":"5278_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1310\/hct0904-238","volume":"9","author":"TJ Podsadecki","year":"2008","unstructured":"Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ (2008) \u201cWhite coat compliance\u201d limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 9:238\u2013246","journal-title":"HIV Clin Trials"},{"key":"5278_CR10","first-page":"461","volume":"41","author":"SH Khoo","year":"2006","unstructured":"Khoo SH, Lloyd J, Dalton M, Bonington A, Hart E, Gibbons S, Flegg P, Sweeney J, Wilkins EG, Back DJ (2006) Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)\u2014a randomized controlled trial of therapeutic drug monitoring and adherence support. J AIDS 41:461\u2013467","journal-title":"J AIDS"},{"key":"5278_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007691-200302000-00011","volume":"25","author":"DM Burger","year":"2003","unstructured":"Burger DM, Hugen PW, Aarnoutse RE, Hoetelmans RM, Jambroes M, Nieuwkerk PT, Schreij G, Schneider MM, van der Ende ME, Lange JM (2003) Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations. Ther Drug Monit 25:73\u201380","journal-title":"Ther Drug Monit"},{"key":"5278_CR12","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-200211220-00011","volume":"16","author":"P Clevenbergh","year":"2002","unstructured":"Clevenbergh P, Garraffo R, Durant J, Dellamonica P (2002) PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12\u00a0week results. AIDS 16:2311\u20132315","journal-title":"AIDS"},{"issue":"Suppl 1","key":"5278_CR13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00002030-200203001-00002","volume":"16","author":"D Back","year":"2002","unstructured":"Back D, Gatti G, Fletcher C, Garaffo R, Haubrich R, Hoetelmans R, Kurowski M, Luber A, Merry C, Perno CF (2002) Therapeutic drug monitoring in HIV infection: current status and future directions. AIDS 16(Suppl 1):S5\u2013S37","journal-title":"AIDS"},{"key":"5278_CR14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.ftd.0000211825.57984.41","volume":"28","author":"D Back","year":"2006","unstructured":"Back D, Gibbons S, Khoo S (2006) An update on therapeutic drug monitoring for antiretroviral drugs. Ther Drug Monit 28:468\u2013473","journal-title":"Ther Drug Monit"},{"key":"5278_CR15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1086\/501458","volume":"42","author":"RE Nettles","year":"2006","unstructured":"Nettles RE, Kieffer TL, Parsons T, Johnson J, Cofrancesco J Jr, Gallant JE, Carson KA, Siliciano RF, Flexner C (2006) Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring. Clin Infec Dis 42:1189\u20131196","journal-title":"Clin Infec Dis"},{"key":"5278_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-4347(99)00059-6","volume":"733","author":"Y Nakahara","year":"1999","unstructured":"Nakahara Y (1999) Hair analysis for abused and therapeutic drugs. J Chromatogr B Biomed Sci Appl 733:161\u2013180","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"5278_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-199325020-00001","volume":"25","author":"T Uematsu","year":"1993","unstructured":"Uematsu T (1993) Therapeutic drug monitoring in hair samples. Principles and practice. Clin Pharmacokin 25:83\u201387","journal-title":"Clin Pharmacokin"},{"key":"5278_CR18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-137-8-200210150-00016","volume":"137","author":"M Gandhi","year":"2002","unstructured":"Gandhi M, Greenblatt RM (2002) Hair it is: the long and short of monitoring antiretroviral treatment. Ann Intern Med 137:696\u2013697","journal-title":"Ann Intern Med"},{"key":"5278_CR19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1742-1241.2001.tb11062.x","volume":"55","author":"JH Beumer","year":"2001","unstructured":"Beumer JH, Bosman IJ, Maes RA (2001) Hair as a biological specimen for therapeutic drug monitoring. Int J Clin Pract 55:353\u2013357","journal-title":"Int J Clin Pract"},{"key":"5278_CR20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-137-8-200210150-00009","volume":"137","author":"L Bernard","year":"2002","unstructured":"Bernard L, Vuagnat A, Peytavin G, Hallouin MC, Bouhour D, Nguyen TH, Vild\u00e9 JL, Bricaire F, Raguin G, de Truchis P, Ghez D, Duong M, Perronne C (2002) Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy. Ann Intern Med 137:656\u2013659","journal-title":"Ann Intern Med"},{"key":"5278_CR21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00002030-200105040-00019","volume":"15","author":"J Servais","year":"2001","unstructured":"Servais J, Peytavin G, Arendt V, Staub T, Schneider F, Hemmer R, Burtonboy G, Schmit JC (2001) Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance. AIDS 15:941\u2013943","journal-title":"AIDS"},{"key":"5278_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/QAD.0b013e3280118486","volume":"21","author":"X Duval","year":"2007","unstructured":"Duval X, Peytavin G, Breton G, Ecobichon JL, Descamps D, Thabut G, Leport C (2007) Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir\/ritonavir combination. AIDS 21:106\u2013108","journal-title":"AIDS"},{"key":"5278_CR23","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1002\/rcm.3750","volume":"22","author":"Y Huang","year":"2008","unstructured":"Huang Y, Gandhi M, Greenblatt RM, Gee W, Lin ET, Messenkoff N (2008) Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom 22:3401\u20133409","journal-title":"Rapid Commun Mass Spectrom"},{"key":"5278_CR24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QAD.0b013e328325a4a9","volume":"23","author":"M Gandhi","year":"2009","unstructured":"Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM (2009) Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS 23:471\u2013478","journal-title":"AIDS"},{"key":"5278_CR25","doi-asserted-by":"crossref","unstructured":"Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, Greenblatt RM (2011) Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis 52:1267\u20131275","DOI":"10.1093\/cid\/cir131"},{"key":"5278_CR26","unstructured":"Gandhi M, Ameli N, Bacchetti P, Huang Y, Gange SJ, Anastos K, Levine A, Cohen M, Young M, Greenblatt RM (2009) Concentrations of Efavirenz in Hair Are Strongly Correlated with Virologic Response. 16th Conference on Retroviruses and Opportunistic Infections (CROI), Montreal, Canada, February 8\u201311"},{"key":"5278_CR27","first-page":"333","volume":"56","author":"GU Zyl van","year":"2011","unstructured":"van Zyl GU, van Mens TE, Mcilleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G (2011) Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J AIDS 56:333\u2013339","journal-title":"J AIDS"},{"key":"5278_CR28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/13543784.5.9.1183","volume":"5","author":"R Murphy","year":"1996","unstructured":"Murphy R, Montaner J (1996) Nevirapine: a review of its development, pharmacological profile and potential for clinical use. J Expert Opinion on Investigational Drugs 5:1183\u20131199","journal-title":"J Expert Opinion on Investigational Drugs"},{"issue":"Suppl 1","key":"5278_CR29","first-page":"S67","volume":"34","author":"JL Sullivan","year":"2003","unstructured":"Sullivan JL (2003) Prevention of mother-to-child transmission of HIV\u2013what next? J AIDS 34(Suppl 1):S67\u2013S72","journal-title":"J AIDS"},{"key":"5278_CR30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1345\/aph.1E563","volume":"39","author":"M Duong","year":"2005","unstructured":"Duong M, Buisson M, Peytavin G, Kohli E, Piroth L, Martha B, Grappin M, Chavanet P, Portier H (2005) Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors. Ann Pharmacother 39:603\u2013609","journal-title":"Ann Pharmacother"},{"key":"5278_CR31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00002030-200201250-00020","volume":"16","author":"D Gonzalez de Requena","year":"2002","unstructured":"Gonzalez de Requena D, Nunez M, Jimenez-Nacher I, Soriano V (2002) Liver toxicity caused by nevirapine. AIDS 16:290\u2013291","journal-title":"AIDS"},{"key":"5278_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00002018-200932020-00007","volume":"32","author":"JM McKoy","year":"2009","unstructured":"McKoy JM, Bennett CL, Scheetz MH, Differding V, Chandler KL, Scarsi KK, Yarnold PR, Sutton S, Palella F, Johnson S, Obadina E, Raisch DW, Parada JP (2009) Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf 32:147\u2013158","journal-title":"Drug Saf"},{"key":"5278_CR33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00002030-200107060-00007","volume":"15","author":"E Mart\u00ednez","year":"2001","unstructured":"Mart\u00ednez E, Blanco JL, Arnaiz JA, P\u00e9rez-Cuevas JB, Mocroft A, Cruceta A, Marcos MA, Milinkovic A, Garc\u00eda-Viejo MA, Mallolas J, Carn\u00e9 X, Phillips A, Gatell JM (2001) Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS 15:1261\u20131268","journal-title":"AIDS"},{"key":"5278_CR34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","volume":"9","author":"SE Barkan","year":"1998","unstructured":"Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J (1998) The Women\u2019s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9:117\u2013125","journal-title":"Epidemiology"},{"key":"5278_CR35","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1208\/aapsj0901004","volume":"J9","author":"CT Viswanathan","year":"2007","unstructured":"Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R (2007) Workshop\/Conference Report-Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J 9:E30\u2013E42","journal-title":"AAPS"},{"key":"5278_CR36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4155\/bio.10.111","volume":"2","author":"N Spooner","year":"2010","unstructured":"Spooner N (2010) A glowing future for dried blood spot sampling. Bioanalysis 2:1343\u20131344","journal-title":"Bioanalysis"},{"key":"5278_CR37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4155\/bio.10.158","volume":"2","author":"P Amsterdam","year":"2010","unstructured":"Amsterdam P, Waldrop C (2010) The application of dried blood spot sampling in global clinical trials. Bioanalysis 2:1783\u20131786","journal-title":"Bioanalysis"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-011-5278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-011-5278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-011-5278-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T21:11:12Z","timestamp":1686258672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-011-5278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["5278"],"URL":"https:\/\/doi.org\/10.1007\/s00216-011-5278-7","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}